[Corrigendum] TOOLBOX: Strep‑Tagged nano‑assemblies of antibody‑drug‑conjugates (ADC) for modular and conditional cancer drugging
Affiliations: Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, I‑00144 Rome, Italy, Ibi Lorenzini, I‑04011 Aprilia, Italy, University Hospital Jena, Institute of Biochemistry II, D‑07740 Jena, Italy, IBA GmbH, D‑37079 Göttingen, Germany, SAFU, IRCCS Regina Elena National Cancer Institute, I‑00144 Rome, Italy, NaxosPharma, Novate Milanese, I‑20026 Milan, Italy
- Published online on: June 9, 2021 https://doi.org/10.3892/or.2021.8110
- Article Number: 159
Copyright : © Tremante et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 45: [Related article:] 77, 2021; DOI: 10.3892/or.2021.8028
Following the publication of the above article, the authors have requested a change in the authorship on the paper, and the revised list of authors is presented above; essentially, the ninth intended author, Giuseppe Salvo (G.S.), was inadverently omitted from the author list. G.S. contributed towards the T design and the preparation of the tagged ScFv. Therefore, the revised authors’ names and affiliations, as they should have been presented in the original version of this paper, are as follows:
ELISA TREMANTE1, LEONARDO SIBILIO2,7, FABIO CENTOLA2,8, NADINE KNUTTI3,9, GERD HOLZAPFEL4, ISABELLA MANNI5, MATTEO ALLEGRETTI1, PAOLO LOMBARDI6, GIUSEPPE SALVO2,10, LOREDANA CECCHETELLI2, KARLHEINZ FRIEDRICH3, JOACHIM BERTRAM4 and PATRIZIO GIACOMINI1
1Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Rome; 2Ibi Lorenzini, Aprilia, Italy; 3University Hospital Jena, Institute of Biochemistry II, Jena; 4IBA GmbH, Göttingen, Germany; 5SAFU, IRCCS Regina Elena National Cancer Institute, Rome; 6NaxosPharma, Novate Milanese, Milan, Italy
Correspondence to: Dr Patrizio Giacomini. Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy, E-mail: firstname.lastname@example.org
Present address: 7Menarini Biotech, Pomezia, Rome, Italy
Present address: 8Merck Serono Spa, Global Analytical Department, Guidonia Montecelio, Rome, Italy
Present address: 9University Hospital Jena Institute for Clinical Chemistry and Laboratory Diagnostics, Jena, Germany
Present address: 10External Quality Assurance (ExM), MSD Italia S.r.l., Via Vitorchiano 151, 00189 Rome, Italy
Furthermore, the Authors contributions section should be amended to read as follows:
ET and MA tested the TOOLBOX concept and performed the flow cytometry experiments. LS, FC, GS and LC designed and prepared the tagged ScFv. NK and KF designed and prepared the GFP promoter-reporter construct. GH and JB designed and manufactured Strep-Tactins. ET and IM performed animal studies. PL designed and manufactured NAX and NAXT compounds. PG conceptualized TOOLBOX and wrote the manuscript with the contribution of all authors. All authors have approved the final version of the manuscript.
All the authors agree with the inclusion of Giuseppe Salvo as an author on this paper, and are grateful to the Editor for allowing them the opportunity to publish this Corrigendum. Furthermore, they apologize to the readership of the Journal for any inconvenience caused.